Orchestra BioMed Holdings, Inc. (OBIO)

Orchestra BioMed Holdings Revenue

In the year 2025, Orchestra BioMed Holdings had annual revenue of $33.48M with 1,169.22% growth. Orchestra BioMed Holdings had revenue of $30.92M in the quarter ending December 31, 2025, with 12,120.16% growth.

• Revenue (ttm): $33.48M
• Revenue Growth: +1,169.22%
• P/S Ratio: 7.26
• Revenue / Employee: $389,326
• Employees: 86
• Market Cap: 243.12M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	33.48M	30.84M	1,169.22%
Dec 31, 2024	2.64M	-122.00K	-4.42%
Dec 31, 2023	2.76M	-773.00K	-21.88%
Dec 31, 2022	3.53M	4.32M	-
Dec 31, 2021	-782.00K	-6.49M	-

Data Source: S&P Global Market Intelligence Last updated: Mar 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 12, 2026

Data Sources Report a data error